New Edition,is a eugeroic (wakefulness-promoting) agent

The term "crl-40 peptide" often points towards a class of compounds that, despite the "peptide" designation, are actually synthetic molecules with significant implications in the realm of wakefulness promotion and cognitive enhancement. The primary substances associated with this search are Fladrafinil (CRL-40,941) and its close relative, Flmodafinil (CRL-40,940). These compounds are structurally related to well-known agents like modafinil and adrafinil, and understanding their properties requires a closer look at their development and potential applications.

Fladrafinil (CRL-40,941) is frequently identified as a nootropic and a wakefulness-promoting agent. Discovered by French pharmacists at Lafon Laboratories, it belongs to the eugeroic class of substances, meaning they promote wakefulness. Its developmental code name, CRL-40,941, is a key identifier in scientific literature and product listings. Some sources also refer to it as fluorafinil or bisfluoroadrafinil, highlighting its chemical modifications compared to its predecessors. While not a true peptide, the "crl-40 peptide" search may arise from a misunderstanding or a broader categorization of research chemicals. It's important to clarify that real peptides are amino-acid polymers, whereas CRL-40,941 is a synthetic small molecule.

Similarly, Flmodafinil (CRL-40,940), also known by names such as bisfluoromodafinil and lauflumide, is another wakefulness-promoting agent. Its developmental code names include CRL-40,940, NLS-4, and JBG01-41. This compound is also a synthetic eugeroic compound and is structurally related to modafinil and adrafinil. Both CRL-40,940 and CRL-40,941 have been explored in preclinical research for their potential interactions with neurotransmitter systems.

Chemical Identity and Structural Relationships

The chemical structures of these compounds are key to understanding their function. Fladrafinil (CRL-40,941) has a CAS Number of 90212-80-9 and its molecular formula is C15H13F2NO3S. Its molecular weight is also a significant parameter for identification. Flmodafinil (CRL-40,940), on the other hand, is associated with CAS No.: 90280-13-0. Both compounds are characterized by the presence of fluorine atoms, differentiating them from adrafinil and modafinil. The formation of degradation products, such as 1,1,2,2-tetraphenylethane and its tetrafluoro derivatives, has been investigated during the thermal analysis of these compounds in GC injectors, indicating their stability characteristics under specific conditions.

Potential Applications and Research Areas

The primary function associated with CRL-40 peptide compounds, particularly Fladrafinil (CRL-40,941) and Flmodafinil (CRL-40,940), is the promotion of wakefulness. They are often explored for their potential in combating sleep disorders causing excessive sleepiness, such as narcolepsy, sleep apnea, and shift work sleep disorders. Anecdotal reports sometimes suggest a warm and euphoric feeling associated with Fladrafinil, though this is highly subjective and not universally reported.

Beyond wakefulness, these compounds are being researched for a broader range of applications. Flmodafinil (CRL-40,940) is involved in investigating mechanisms of neuronal resilience, cellular protection, and stress-related signaling pathways. Furthermore, there is ongoing research into their potential for treating various ailments including ADHD, Alzheimer's Disease, and other cognitive impairments. The high purity of these compounds, often advertised as High purity 99.6% Pharmaceutical Raw Nootropic Crl-40, is a crucial factor for research and potential therapeutic applications.

Research Chemicals and Regulatory Status

It is critical to note that both Fladrafinil (CRL-40,941) and Flmodafinil (CRL-40,940) are often classified as research chemicals or analytical reference standards. This means they are intended for laboratory research and forensic applications and are not approved for human consumption by regulatory bodies. Listings for CRL-40,941 consistently describe a synthetic small molecule, reinforcing its distinction from actual peptides.

Suppliers often emphasize high purity 99%+ and GMP manufactured or 3rd party lab tested products when offering CRL-40,940 (Flmodafinil) For Sale. However, the classification as a research chemical means that availability for purchase is generally restricted to entities involved in scientific research. Some products are explicitly stated to be authorized for distribution within the EU for exclusive use in laboratory settings.

Key Ident